Compare NKE & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NKE | GSK |
|---|---|---|
| Founded | 1964 | 1715 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Shoe Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 94.9B | 95.3B |
| IPO Year | 1980 | N/A |
| Metric | NKE | GSK |
|---|---|---|
| Price | $67.42 | $48.82 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 25 | 1 |
| Target Price | ★ $82.38 | N/A |
| AVG Volume (30 Days) | ★ 13.0M | 4.2M |
| Earning Date | 12-18-2025 | 10-29-2025 |
| Dividend Yield | 2.43% | ★ 3.40% |
| EPS Growth | N/A | ★ 118.57 |
| EPS | ★ 1.95 | 1.79 |
| Revenue | ★ $46,440,000,000.00 | $43,237,357,842.00 |
| Revenue This Year | $1.92 | $6.56 |
| Revenue Next Year | $5.19 | $5.13 |
| P/E Ratio | $34.64 | ★ $13.25 |
| Revenue Growth | N/A | ★ 2.73 |
| 52 Week Low | $52.28 | $31.72 |
| 52 Week High | $82.44 | $49.31 |
| Indicator | NKE | GSK |
|---|---|---|
| Relative Strength Index (RSI) | 59.47 | 60.04 |
| Support Level | $62.97 | $47.20 |
| Resistance Level | $66.66 | $49.31 |
| Average True Range (ATR) | 1.68 | 0.61 |
| MACD | 0.51 | -0.04 |
| Stochastic Oscillator | 77.96 | 81.02 |
Nike is the largest athletic footwear and apparel brand in the world. Footwear generates about two-thirds of its sales. Key performance footwear categories include basketball, running, and football (soccer). Its brands include Nike, Jordan (premium athletic footwear and clothing), NikeSkims (women's athleisure), and Converse (casual footwear). Nike sells products worldwide through company-owned stores, franchised stores (including about 5,500 in China), and third-party retailers. The firm also operates e-commerce platforms in more than 40 countries. Nearly all its production is outsourced to contract manufacturers in more than 30 countries. Nike was founded in 1964 and is based in Beaverton, Oregon.
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.